These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 16787769
1. Prophylactic and therapeutic use of recombinant activated factor VII in patients with cirrhosis and coagulation impairment. Tsochatzis E, Papatheodoridis GV, Elefsiniotis I, Thanelas S, Theodossiades G, Moulakakis A, Archimandritis AJ. Dig Liver Dis; 2007 May; 39(5):490-4. PubMed ID: 16787769 [Abstract] [Full Text] [Related]
2. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage. Brady KM, Easley RB, Tobias JD. Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833 [Abstract] [Full Text] [Related]
3. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials. Rizoli SB, Boffard KD, Riou B, Warren B, Iau P, Kluger Y, Rossaint R, Tillinger M, NovoSeven Trauma Study Group. Crit Care; 2006 Oct; 10(6):R178. PubMed ID: 17184516 [Abstract] [Full Text] [Related]
4. The use of recombinant factor VIIa in liver diseases. Franchini M, Montagnana M, Targher G, Zaffanello M, Lippi G. Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080 [Abstract] [Full Text] [Related]
5. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry. Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P. Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152 [Abstract] [Full Text] [Related]
7. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review. Jirapinyo M, Manonai J, Herabutya Y, Chuncharunee S. J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055 [Abstract] [Full Text] [Related]
8. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K. Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474 [Abstract] [Full Text] [Related]
9. FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases. Pavese P, Bonadona A, Beaubien J, Labrecque P, Pernod G, Letoublon C, Barnoud D. Can J Anaesth; 2005 Jan; 52(1):26-9. PubMed ID: 15625252 [Abstract] [Full Text] [Related]
10. Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa. Mindikoglu AL, Anantharaju A, George M, Leone N, Bejna J, Van Thiel DH. Hepatogastroenterology; 2003 Jan; 50(53):1697-9. PubMed ID: 14571820 [Abstract] [Full Text] [Related]
11. Successful treatment of massive acute lower gastrointestinal bleeding in diverticular disease of colon, with activated recombinant factor VII (NovoSeven). Ali ZS, Al-Shaalan H, Jorgensen J. Blood Coagul Fibrinolysis; 2006 Jun; 17(4):327-9. PubMed ID: 16651879 [Abstract] [Full Text] [Related]
12. [New possibilities in the postoperative measures to prevent bleeding in cardiac surgery. Will the recombinant activated factor VII improve surgical results?]. Skalski JH, Czapla J, Nadziakiewicz P, Kaczmarski J, Zembala M. Przegl Lek; 2002 Jun; 59(11):941-5. PubMed ID: 12715727 [Abstract] [Full Text] [Related]
13. Consensus protocol for the use of recombinant activated factor VII [eptacog alfa (activated); NovoSeven] in elective orthopaedic surgery in haemophilic patients with inhibitors. Giangrande PL, Wilde JT, Madan B, Ludlam CA, Tuddenham EG, Goddard NJ, Dolan G, Ingerslev J. Haemophilia; 2009 Mar; 15(2):501-8. PubMed ID: 19187194 [Abstract] [Full Text] [Related]
14. Use of recombinant factor VIIa in pediatric patients with liver failure and severe coagulopathy. Atkison PR, Jardine L, Williams S, Barr RM, Quan D, Wall W. Transplant Proc; 2005 Mar; 37(2):1091-3. PubMed ID: 15848632 [Abstract] [Full Text] [Related]
15. Benefits of recombinant activated factor VII in complicated liver transplantation. Gala B, Quintela J, Aguirrezabalaga J, Fernández C, Fraguela J, Suárez F, Gómez M. Transplant Proc; 2005 Nov; 37(9):3919-21. PubMed ID: 16386584 [Abstract] [Full Text] [Related]
16. The use of recombinant activated factor VII to control bleeding during repair of a suprarenal abdominal aortic aneurysm. Wahlgren CM, Swedenborg J. Eur J Vasc Endovasc Surg; 2003 Aug; 26(2):221-2. PubMed ID: 12917843 [Abstract] [Full Text] [Related]
17. Prophylactic effect of recombinant factor VIIa in factor VII deficient patients. Mathijssen NC, Masereeuw R, Verbeek K, Lavergne JM, Costa JM, van Heerde WL, Nováková IR. Br J Haematol; 2004 May; 125(4):494-9. PubMed ID: 15142120 [Abstract] [Full Text] [Related]
18. Efficacy and safety of activated recombinant factor VII in cardiac surgical patients. Hardy JF, Bélisle S, Van der Linden P. Curr Opin Anaesthesiol; 2009 Feb; 22(1):95-9. PubMed ID: 19295298 [Abstract] [Full Text] [Related]
19. Experience of recombinant activated factor VII (NovoSeven) in the operating theatre and intensive care unit for the management of intracranial bleeding in nonhaemophilic patients. Felfernig M, Huepfl M. Clin Neurol Neurosurg; 2008 Mar; 110(3):227-32. PubMed ID: 18083302 [Abstract] [Full Text] [Related]
20. Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial. Shao YF, Yang JM, Chau GY, Sirivatanauksorn Y, Zhong SX, Erhardtsen E, Nivatvongs S, Lee PH. Am J Surg; 2006 Feb; 191(2):245-9. PubMed ID: 16442954 [Abstract] [Full Text] [Related] Page: [Next] [New Search]